BofA upgraded Surgery Partners (SGRY) to Buy from Neutral with a $28 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- TD says CMS hospital rules positive for Surgery Partners, negative for HCA
- Positive Outlook for Surgery Partners Amid CMS Regulatory Changes Boosting ASC Opportunities
- Surgery Partners Decides to Remain Independent
- Surgery Partners, Bain Capital conclude discussions
- Surgery Partners reaffirms FY25 revenue view $3.3B-$3.45B, consensus $3.38B